Lawrence D. Rosenberg

Jones Day (Washington DC)
Lawyer (Partner)

Larry Rosenberg is Partner at Jones Day (Washington). He is a litigator who has tried cases and argued appeals throughout the country and been lead counsel in numerous matters in the United States Supreme Court. Larry has considerable experience in regulatory, statutory and constitutional litigation, intellectual property, antitrust, international litigation, labor and employment, products liability, and securities litigation. He has litigated cases involving the U.S. Departments of Agriculture, Education, Energy, HHS, Homeland Security, Interior, Justice, State, and Transportation, as well as the EPA, EEOC, FAA, FCC, FDA, FERC, FTC, and USPS. Larry also has been counsel in more than 20 appeals in the Federal Circuit. His clients include American Airlines, American Electric Power, Bayer, CBS, Chevron, Continental Airlines, General Electric, Nokia, Pfizer, Procter & Gamble, Quorum Health, Texas Instruments, and Trinity Broadcasting Network. Larry is lead counsel for Chevron in a fraudulent breach of contract suit against the government, recently won a victory in the U.S. Supreme Court for a refugee from Cameroon seeking asylum, and was lead counsel for seven airlines in successfully challenging an FAA rule. He represents Bayer in several antitrust class actions challenging settlement of patent litigation and represents CBS in a series of age discrimination class actions. Larry is court-appointed appellate counsel for Adham Hassoun, who was convicted of terrorism-related charges involving Jose Padilla. Larry is a co-chair of the Trial Practice Committee of the American Bar Association’s Litigation Section. He also is a principal author of A Practitioner’s Guide To Appellate Advocacy and regularly speaks and writes on a variety of legal subjects.

Linked author

Jones Day (Washington DC)

Articles

68 Bulletin

Kevin D. McDonald, Lawrence D. Rosenberg A US Court of Appeals holds the use of cash payments to settle Hatch-Waxman patent litigation does not violate the antitrust laws if the settlement does not exceed the scope of patent and claim for patent validity is not a sham (Bayer/Barr)

68

On October 15, 2008, the Federal Circuit joined the growing list of federal courts to hold that the use of cash payments to settle Hatch-Waxman patent litigation does not violate the antitrust laws as long as (1) the settlement excludes no more competition than would the patent itself and (2) (...)

Send a message